2023-03-012024-02-292024-02-29false07557149AESTHETIC DENTAL STUDIO LIMITED2024-10-31iso4217:GBPxbrli:pure075571492023-03-01075571492024-02-29075571492023-03-012024-02-29075571492022-03-01075571492023-02-28075571492022-03-012023-02-2807557149bus:SmallEntities2023-03-012024-02-2907557149bus:AuditExempt-NoAccountantsReport2023-03-012024-02-2907557149bus:FullAccounts2023-03-012024-02-2907557149bus:PrivateLimitedCompanyLtd2023-03-012024-02-2907557149core:WithinOneYear2024-02-2907557149core:AfterOneYear2024-02-2907557149core:WithinOneYear2023-02-2807557149core:AfterOneYear2023-02-2807557149core:ShareCapital2024-02-2907557149core:SharePremium2024-02-2907557149core:RevaluationReserve2024-02-2907557149core:OtherReservesSubtotal2024-02-2907557149core:RetainedEarningsAccumulatedLosses2024-02-2907557149core:ShareCapital2023-02-2807557149core:SharePremium2023-02-2807557149core:RevaluationReserve2023-02-2807557149core:OtherReservesSubtotal2023-02-2807557149core:RetainedEarningsAccumulatedLosses2023-02-2807557149core:LandBuildings2024-02-2907557149core:PlantMachinery2024-02-2907557149core:Vehicles2024-02-2907557149core:FurnitureFittings2024-02-2907557149core:OfficeEquipment2024-02-2907557149core:NetGoodwill2024-02-2907557149core:IntangibleAssetsOtherThanGoodwill2024-02-2907557149core:ListedExchangeTraded2024-02-2907557149core:UnlistedNon-exchangeTraded2024-02-2907557149core:LandBuildings2023-02-2807557149core:PlantMachinery2023-02-2807557149core:Vehicles2023-02-2807557149core:FurnitureFittings2023-02-2807557149core:OfficeEquipment2023-02-2807557149core:NetGoodwill2023-02-2807557149core:IntangibleAssetsOtherThanGoodwill2023-02-2807557149core:ListedExchangeTraded2023-02-2807557149core:UnlistedNon-exchangeTraded2023-02-2807557149core:LandBuildings2023-03-012024-02-2907557149core:PlantMachinery2023-03-012024-02-2907557149core:Vehicles2023-03-012024-02-2907557149core:FurnitureFittings2023-03-012024-02-2907557149core:OfficeEquipment2023-03-012024-02-2907557149core:NetGoodwill2023-03-012024-02-2907557149core:IntangibleAssetsOtherThanGoodwill2023-03-012024-02-2907557149core:ListedExchangeTraded2023-03-012024-02-2907557149core:UnlistedNon-exchangeTraded2023-03-012024-02-2907557149core:MoreThanFiveYears2023-03-012024-02-2907557149core:Non-currentFinancialInstruments2024-02-2907557149core:Non-currentFinancialInstruments2023-02-2807557149dpl:CostSales2023-03-012024-02-2907557149dpl:DistributionCosts2023-03-012024-02-2907557149core:LandBuildings2023-03-012024-02-2907557149core:PlantMachinery2023-03-012024-02-2907557149core:Vehicles2023-03-012024-02-2907557149core:FurnitureFittings2023-03-012024-02-2907557149core:OfficeEquipment2023-03-012024-02-2907557149dpl:AdministrativeExpenses2023-03-012024-02-2907557149core:NetGoodwill2023-03-012024-02-2907557149core:IntangibleAssetsOtherThanGoodwill2023-03-012024-02-2907557149dpl:GroupUndertakings2023-03-012024-02-2907557149dpl:ParticipatingInterests2023-03-012024-02-2907557149dpl:GroupUndertakingscore:ListedExchangeTraded2023-03-012024-02-2907557149core:ListedExchangeTraded2023-03-012024-02-2907557149dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-03-012024-02-2907557149core:UnlistedNon-exchangeTraded2023-03-012024-02-2907557149dpl:CostSales2022-03-012023-02-2807557149dpl:DistributionCosts2022-03-012023-02-2807557149core:LandBuildings2022-03-012023-02-2807557149core:PlantMachinery2022-03-012023-02-2807557149core:Vehicles2022-03-012023-02-2807557149core:FurnitureFittings2022-03-012023-02-2807557149core:OfficeEquipment2022-03-012023-02-2807557149dpl:AdministrativeExpenses2022-03-012023-02-2807557149core:NetGoodwill2022-03-012023-02-2807557149core:IntangibleAssetsOtherThanGoodwill2022-03-012023-02-2807557149dpl:GroupUndertakings2022-03-012023-02-2807557149dpl:ParticipatingInterests2022-03-012023-02-2807557149dpl:GroupUndertakingscore:ListedExchangeTraded2022-03-012023-02-2807557149core:ListedExchangeTraded2022-03-012023-02-2807557149dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-03-012023-02-2807557149core:UnlistedNon-exchangeTraded2022-03-012023-02-2807557149core:NetGoodwill2024-02-2907557149core:IntangibleAssetsOtherThanGoodwill2024-02-2907557149core:LandBuildings2024-02-2907557149core:PlantMachinery2024-02-2907557149core:Vehicles2024-02-2907557149core:FurnitureFittings2024-02-2907557149core:OfficeEquipment2024-02-2907557149core:AfterOneYear2024-02-2907557149core:WithinOneYear2024-02-2907557149core:ListedExchangeTraded2024-02-2907557149core:UnlistedNon-exchangeTraded2024-02-2907557149core:ShareCapital2024-02-2907557149core:SharePremium2024-02-2907557149core:RevaluationReserve2024-02-2907557149core:OtherReservesSubtotal2024-02-2907557149core:RetainedEarningsAccumulatedLosses2024-02-2907557149core:NetGoodwill2023-02-2807557149core:IntangibleAssetsOtherThanGoodwill2023-02-2807557149core:LandBuildings2023-02-2807557149core:PlantMachinery2023-02-2807557149core:Vehicles2023-02-2807557149core:FurnitureFittings2023-02-2807557149core:OfficeEquipment2023-02-2807557149core:AfterOneYear2023-02-2807557149core:WithinOneYear2023-02-2807557149core:ListedExchangeTraded2023-02-2807557149core:UnlistedNon-exchangeTraded2023-02-2807557149core:ShareCapital2023-02-2807557149core:SharePremium2023-02-2807557149core:RevaluationReserve2023-02-2807557149core:OtherReservesSubtotal2023-02-2807557149core:RetainedEarningsAccumulatedLosses2023-02-2807557149core:NetGoodwill2022-03-0107557149core:IntangibleAssetsOtherThanGoodwill2022-03-0107557149core:LandBuildings2022-03-0107557149core:PlantMachinery2022-03-0107557149core:Vehicles2022-03-0107557149core:FurnitureFittings2022-03-0107557149core:OfficeEquipment2022-03-0107557149core:AfterOneYear2022-03-0107557149core:WithinOneYear2022-03-0107557149core:ListedExchangeTraded2022-03-0107557149core:UnlistedNon-exchangeTraded2022-03-0107557149core:ShareCapital2022-03-0107557149core:SharePremium2022-03-0107557149core:RevaluationReserve2022-03-0107557149core:OtherReservesSubtotal2022-03-0107557149core:RetainedEarningsAccumulatedLosses2022-03-0107557149core:AfterOneYear2023-03-012024-02-2907557149core:WithinOneYear2023-03-012024-02-2907557149core:Non-currentFinancialInstrumentscore:CostValuation2023-03-012024-02-2907557149core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-012024-02-2907557149core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-012024-02-2907557149core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-012024-02-2907557149core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-012024-02-2907557149core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-012024-02-2907557149core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-012024-02-2907557149core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-012024-02-2907557149core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-012024-02-2907557149core:Non-currentFinancialInstrumentscore:CostValuation2024-02-2907557149core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-02-2907557149core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-02-2907557149core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-02-2907557149core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-02-2907557149core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-02-2907557149core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-02-2907557149core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-02-2907557149core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-02-2907557149core:Non-currentFinancialInstrumentscore:CostValuation2023-02-2807557149core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-02-2807557149core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-02-2807557149core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-02-2807557149core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-02-2807557149core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-02-2807557149core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-02-2807557149core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-02-2807557149core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-02-2807557149bus:Director12023-03-012024-02-29

AESTHETIC DENTAL STUDIO LIMITED

Registered Number
07557149
(England and Wales)

Unaudited Financial Statements for the Year ended
29 February 2024

AESTHETIC DENTAL STUDIO LIMITED
Company Information
for the year from 1 March 2023 to 29 February 2024

Director

TOWLERTON, Andrew James

Company Secretary

TOWLERTON, Andrew James

Registered Address

The Dairy 19 Home Farm Close
Kelham
Newark
NG23 5QB

Registered Number

07557149 (England and Wales)
AESTHETIC DENTAL STUDIO LIMITED
Statement of Financial Position
29 February 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Intangible assets311
Tangible assets4163,777137,732
163,778137,733
Current assets
Debtors561,88715,678
Cash at bank and on hand54,38556,835
116,27272,513
Creditors amounts falling due within one year6(67,546)(40,937)
Net current assets (liabilities)48,72631,576
Total assets less current liabilities212,504169,309
Creditors amounts falling due after one year7(14,941)(18,936)
Provisions for liabilities9(18,220)(20,404)
Net assets179,343129,969
Capital and reserves
Called up share capital100100
Profit and loss account179,243129,869
Shareholders' funds179,343129,969
The financial statements were approved and authorised for issue by the Director on 31 October 2024, and are signed on its behalf by:
TOWLERTON, Andrew James
Director
Registered Company No. 07557149
AESTHETIC DENTAL STUDIO LIMITED
Notes to the Financial Statements
for the year ended 29 February 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 Section 1A, The Financial Reporting Standard applicable in the UK and Republic of Ireland.
Basis of preparation
The financial statements have been prepared on the historical cost basis.
Going concern
The UK economy has recently been impacted by rising inflation, interest rates and energy costs, exacerbated by the war in Ukraine. All these matters have impacted the company's trading results to a greater or lesser extent. At the date of signing these financial statements, the directors have considered the effect of these matters on the company with the information available to it and do not believe that it will affect the ability of the company to continue to trade for the foreseeable future. On this basis, the directors have prepared these financial statements on a going concern basis.
Revenue from sale of goods
The revenue shown in the profit and loss account represents income receivable from dental treatments carried out during the period. Revenue in respect of dental treatment uncompleted at the year end date is recognised by reference to the state of completion.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
Current taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amount of tax expected to pay or recover using the tax rates and laws that have been enacted, or substantively enacted, at the reporting date.
Deferred tax
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted, or substantively enacted, by the reporting date that are expected to apply to the reversal of the timing difference.
Intangible assets
Goodwill arises on business acquisitions and represents the excess of the cost of the acquisition over the company's interest in the net amount of the identifiable assets, liabilities and contingent liabilities of the acquired business. Goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. It is amortised on a straight-line basis over its useful life. Where a reliable estimate of the useful life of goodwill or intangible assets cannot be made, the life is presumed not to exceed ten years.
Tangible fixed assets and depreciation
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Finance leases and hire purchase contracts
Assets held under finance leases and hire purchase contracts are recognised in the statement of financial position as assets and liabilities at the lower of the fair value of the assets and the present value of the minimum lease payments, which is determined at the inception of the lease term. Any initial direct costs of the lease are added to the amount recognised as an asset. Lease payments are apportioned between the finance charges and reduction of the outstanding lease liability using the effective interest method. Finance charges are allocated to each period so as to produce a constant rate of interest on the remaining balance of the liability.
Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
2.Average number of employees

20242023
Average number of employees during the year11
3.Intangible assets

Other

Total

££
Cost or valuation
At 01 March 23278,050278,050
At 29 February 24278,050278,050
Amortisation and impairment
At 01 March 23278,049278,049
At 29 February 24278,049278,049
Net book value
At 29 February 2411
At 28 February 2311
4.Tangible fixed assets

Plant & machinery

Vehicles

Office Equipment

Total

££££
Cost or valuation
At 01 March 23250,00981,47814,214345,701
Additions16,76767,7951,18885,750
Disposals(2,070)(52,928)(3,320)(58,318)
At 29 February 24264,70696,34512,082373,133
Depreciation and impairment
At 01 March 23161,80336,10710,059207,969
Charge for year11,43217,2131,23829,883
On disposals(1,151)(25,829)(1,516)(28,496)
At 29 February 24172,08427,4919,781209,356
Net book value
At 29 February 2492,62268,8542,301163,777
At 28 February 2388,20645,3714,155137,732
5.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables31,50114,117
Amounts owed by group undertakings24,7671,561
Other debtors5,619-
Total61,88715,678
6.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables1,1941,326
Bank borrowings and overdrafts3,8508,612
Amounts owed to related parties591,259
Taxation and social security59,40226,731
Other creditors413386
Accrued liabilities and deferred income2,6282,623
Total67,54640,937
7.Creditors: amounts due after one year

2024

2023

££
Bank borrowings and overdrafts14,94118,936
Total14,94118,936
8.Obligations under finance leases
9.Provisions for liabilities

2024

2023

££
Net deferred tax liability (asset)18,22020,404
Total18,22020,404
10.Related party transactions
During the year, the company operated a directors loan account with the directors. This loan was repayable on demand. At the year end date, the company owed the directors £59 (2023: £1,259)